Literature DB >> 24703826

Sayana® Press: can it be a "game changer" for reducing unmet need for family planning?

Jeff Spieler1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24703826     DOI： 10.1016/j.contraception.2014.02.010

Source DB:  PubMed          Journal:  Contraception        ISSN： 0010-7824            Impact factor:   3.375


× No keyword cloud information.
  16 in total

1.  Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?

Authors:  Chelsea B Polis; Sharon L Achilles; Zdenek Hel; Janet P Hapgood
Journal:  Contraception       Date:  2017-12-11       Impact factor: 3.375

2.  Pilot Research as Advocacy: The Case of Sayana Press in Kinshasa, Democratic Republic of the Congo.

Authors:  Arsene Binanga; Jane T Bertrand
Journal:  Glob Health Sci Pract       Date:  2016-12-28

3.  Acceptability of the community-level provision of Sayana® Press by medical and nursing students in Kinshasa, Democratic Republic of the Congo.

Authors:  Jane T Bertrand; Paul Bukutuvwidi Makani; Julie Hernandez; Pierre Akilimali; Bitshi Mukengeshayi; Saleh Babazadeh; Arsene Binanga
Journal:  Contraception       Date:  2017-06-21       Impact factor: 3.375

4.  Trends in subcutaneous depot medroxyprogesterone acetate (DMPA-SC) use in Burkina Faso, the Democratic Republic of Congo and Uganda.

Authors:  Philip Anglewicz; Pierre Akilimali; Georges Guiella; Patrick Kayembe; Simon P S Kibira; Fredrick Makumbi; Amy Tsui; Scott Radloff
Journal:  Contracept X       Date:  2019-11-09

5.  Acceptability of the distribution of DMPA-SC by community health workers among acceptors in the rural province of Lualaba in the Democratic Republic of the Congo: a pilot study.

Authors:  Albert Mwembo; Rebecca Emel; Tesky Koba; Jacqueline Bapura Sankoko; Aben Ngay; Rianne Gay; Jane T Bertrand
Journal:  Contraception       Date:  2018-08-14       Impact factor: 3.375

6.  Predictors of DMPA-SC continuation among urban Nigerian women: the influence of counseling quality and side effects.

Authors:  Jenny Liu; Jennifer Shen; Nadia Diamond-Smith
Journal:  Contraception       Date:  2018-05-04       Impact factor: 3.375

7.  An observational study to test the acceptability and feasibility of using medical and nursing students to instruct clients in DMPA-SC self-injection at the community level in Kinshasa.

Authors:  Jane T Bertrand; Dieudonné Bidashimwa; Paul Bakutuvwidi Makani; Julie H Hernandez; Pierre Akilimali; Arsene Binanga
Journal:  Contraception       Date:  2018-08-16       Impact factor: 3.375

8.  Rapid Uptake of the Subcutaneous Injectable in Burkina Faso: Evidence From PMA2020 Cross-Sectional Surveys.

Authors:  Guiella Georges; Turke Shani; Coulibaly Hamadou; Scott Radloff; Choi Yoonjoung
Journal:  Glob Health Sci Pract       Date:  2018-03-30

9.  Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries.

Authors:  Anna Stout; Siri Wood; George Barigye; Alain Kaboré; Daouda Siddo; Ida Ndione
Journal:  Glob Health Sci Pract       Date:  2018-03-30

Review 10.  Self-administration of injectable contraceptives: a systematic review.

Authors:  C R Kim; M S Fønhus; B Ganatra
Journal:  BJOG       Date:  2016-08-23       Impact factor: 6.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.